Omada Health (NASDAQ:OMDA) Stock Price Down 9.3% – Here’s Why

Shares of Omada Health, Inc. (NASDAQ:OMDA) fell 9.3% on Friday . The stock traded as low as $14.94 and last traded at $14.8730. 1,825,262 shares traded hands during mid-day trading, an increase of 50% from the average session volume of 1,218,513 shares. The stock had previously closed at $16.40.

Key Headlines Impacting Omada Health

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Multiple brokerages raised price targets or reiterated buy ratings (signals of analyst confidence and potential upside). Barclays raised its PT to $20 (overweight). Benzinga
• Positive Sentiment: Citizens Jmp raised its target to $21 (market outperform), implying meaningful upside from current levels. Benzinga
• Positive Sentiment: Needham reaffirmed a “buy” rating with a $28 target, the most bullish analyst view published today and supportive of a long‑term growth narrative. Benzinga
• Positive Sentiment: Omada will serve as an independent program administrator in Eli Lilly’s Employer Connect program, expanding access for its GLP‑1 Care Track — a strategic business development that could drive future revenue growth. GlobeNewswire
• Positive Sentiment: Q1 results: EPS of ($0.05) beat the Street ($0.08) and revenue was $78.05M — a modest beat that supports near‑term execution credibility. Press Release / Slide Deck
• Neutral Sentiment: Wells Fargo nudged its target to $18 but kept an “equal weight” rating — a mixed signal that reduces the uniformity of bullish analyst views. Benzinga The Fly
• Neutral Sentiment: FY2026 revenue guidance was raised to $322–$330M versus a $319.1M consensus — a modest beat that supports revenue momentum but isn’t a large surprise. The company’s EPS guidance was not clearly specified in the release, which may leave some uncertainty around near‑term profitability expectations. Slide Deck
• Neutral Sentiment: For detail and color on management comments, see the Q1 earnings call transcript and analyst metric breakdowns — useful for investors assessing guidance cadence and margin trajectory. Earnings Call Transcript Zacks analysis
• Negative Sentiment: Despite the positives, shares are trading lower with above‑average volume — indicating short‑term selling pressure or profit‑taking. That suggests investors are weighing valuation, execution risks, or the lack of clearer EPS guidance. MarketBeat

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Wall Street Zen raised shares of Omada Health from a “hold” rating to a “buy” rating in a report on Saturday, March 14th. Canaccord Genuity Group set a $24.00 price objective on shares of Omada Health in a research report on Friday. Wells Fargo & Company boosted their target price on shares of Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a report on Friday. Barclays increased their target price on shares of Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday. Finally, Morgan Stanley decreased their price target on shares of Omada Health from $32.00 to $30.00 and set an “overweight” rating on the stock in a research report on Friday, March 6th. Ten investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Omada Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.91.

Omada Health Trading Down 10.4%

The stock has a 50-day moving average of $13.55 and a two-hundred day moving average of $15.85. The firm has a market cap of $872.88 million and a price-to-earnings ratio of -86.34.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.03. The company had revenue of $78.05 million for the quarter. Sell-side analysts expect that Omada Health, Inc. will post -0.04 EPS for the current fiscal year.

Insider Activity at Omada Health

In other Omada Health news, President Wei-Li Shao sold 2,829 shares of the business’s stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $12.71, for a total transaction of $35,956.59. Following the sale, the president directly owned 328,850 shares of the company’s stock, valued at $4,179,683.50. The trade was a 0.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Steven L. Cook sold 1,884 shares of the stock in a transaction on Friday, March 13th. The shares were sold at an average price of $13.94, for a total value of $26,262.96. Following the completion of the sale, the chief financial officer owned 200,512 shares of the company’s stock, valued at $2,795,137.28. The trade was a 0.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 8,776 shares of company stock worth $120,483.

Institutional Investors Weigh In On Omada Health

Hedge funds have recently bought and sold shares of the business. BIT Capital GmbH purchased a new stake in shares of Omada Health in the third quarter worth approximately $13,639,000. Divisadero Street Capital Management LP purchased a new position in Omada Health during the third quarter valued at approximately $30,510,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Omada Health in the 4th quarter valued at approximately $1,222,000. Tudor Investment Corp ET AL purchased a new stake in Omada Health in the 3rd quarter worth approximately $987,000. Finally, Fortress Investment Group LLC boosted its stake in shares of Omada Health by 43.1% during the 3rd quarter. Fortress Investment Group LLC now owns 225,000 shares of the company’s stock valued at $4,975,000 after buying an additional 67,750 shares during the period.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.